- £6.14bn
- £3.27bn
- £33.37bn
- 67
- 85
- 28
- 65
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 15,958 | 14,949 | 18,300 | 33,637 | 33,374 |
Cost of Revenue | |||||
Gross Profit | 2,834 | 2,333 | 2,870 | 5,439 | 5,217 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 16,741 | 15,311 | 17,346 | 33,877 | 26,862 |
Operating Profit | -783 | -362 | 954 | -240 | 6,512 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,034 | -577 | 767 | -383 | 6,473 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,044 | -432 | 549 | -636 | 4,040 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1,023 | 41 | 1,210 | -782 | 3,929 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,023 | 41 | 1,210 | -782 | 3,929 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.104 | 0.12 | 0.142 | 0.607 | 0.323 |
Dividends per Share |